4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-22-060970
Chief Operating Officer sold 751 shares at $10.87 ($8,163)
- Chief Operating Officer acquired 44,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2022-12-09 | Grant or award | +44,000 | 112,786 | D | ||
| HIGH SUSANNA GATTI Chief Operating Officer | 2022-12-12 | Sale | −751 | $10.87 | $8,163 | 112,035 | D |
| Derivatives | |||||||
| HIGH SUSANNA GATTI Chief Operating Officer | 2022-12-09 | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | D | ||
| Open-market sales · 751 sh · avg $10.87 · $8,163 | |||||||
Loading xslF345X03/doc4.xml…